| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |